Ledger.Open graph →
SEC Form D · Amendment · filed July 8, 2021

Intrommune Therapeutics, Inc

Offering
$20.0M
Sold
$68K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (8)

Erick Berglund · New York, NYDirectorWilliam Reisacher · New York, NYDirectorScott C. Nagel · SEATTLE, WADirectorRyan C. Mcgavran · SEATTLE, WADirectorMichael Nelson · Columbus, OHExec · DirectorDavid L. Sun · George Town, Grand Cayman, Cayman IslandsDirectorPaul Bell · Boston, MADirectorMichael Nelson · Las Vegas, NVExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗